Clinical development at World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
54 organizations at World Vaccine Congress 2027 present work in clinical & preclinical development: 47 suppliers and service providers, 4 public-health and non-profit bodies, 2 vaccine and drug developers and 1 academic body. Between them they bring 16 presentations to the program. Most represented: Pfizer, AMR Clinical and 360biolabs. As of Oct 8, 2026.
Format
Top represented
Showing 1–17 of 54 organizations
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
Pfizer New York, NY | |
Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases. | Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 |
Integrated network of US clinical research sites with a long track record in vaccine trials. | Booth Exhibiting at Booth 204 |
360biolabs Melbourne, Australia | |
Australian specialist laboratory running virology, immunology and serology assays for vaccine and infectious disease trials. | Booth Exhibiting at Booth 357 Panel Wed Mar 10 14:40 |
Australian GMP-licensed contract manufacturer offering small-batch aseptic fill-finish, labelling and packaging, and microbiology testing. | Panel Wed Mar 10 14:40 |
European Medicines Agency Amsterdam, Netherlands | |
The European Union's medicines regulator, evaluating and monitoring vaccines and medicines. | Keynote Tue Mar 9 15:50 Keynote Panel: The Speed vs. Certainty Paradox: Redefining the Threshold of Evidence for Next-Generation Approvals Whether regulators should keep demanding large late-stage trials or approve vaccines faster on immune markers and real-world safety data. Clinical & preclinical development |
Biotech developing next-generation broad-spectrum vaccines, with candidates in clinical trials. | Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. |
Africa CDC Addis Ababa, Ethiopia | |
Africa Centres for Disease Control and Prevention, the African Union's public health agency for disease surveillance, outbreak response and immunization. | Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. Infectious disease & AMR Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. Clinical & preclinical developmentSupply, safety & access |
Weill Cornell Medicine New York, NY | |
Medical school of Cornell University in New York City. | Talk Wed Mar 10 09:25 Panel Thu Mar 11 09:10 Panel: How to design trials for early life? / Unique challenges of clinical trial design for maternal-fetal transmission? How to design ethical and safe vaccine trials in pregnant people and newborns, including for group B streptococcus and neonatal herpes. |
UK Health Security Agency (UKHSA) London, United Kingdom | |
UK agency that plans for, prevents and responds to health threats, providing scientific and operational leadership nationally and globally. | Booth Exhibiting at Booth 317 |
Biointelect Sydney, Australia | |
Australian consultancy advising life science companies and governments on strategy, market access and policy. | Panel Wed Mar 10 14:40 |
Linear Clinical Research Perth, Australia | |
Australian early-phase clinical trial unit running first-in-human and other early studies. | Panel Wed Mar 10 14:40 |
Network of Australian clinical research sites running phase 1 to 3 trials. | Panel Wed Mar 10 14:40 |
Advanced Virology Athens, OH | |
Supplier of wild-type, reporter and inactivated virus stocks, plus made-to-order viruses and virology research services for biotech, pharma and academic labs. | Booth Exhibiting at Booth 452 |
Network of clinical research sites offering rapid study start-up and diverse participant enrollment for clinical trials. | Booth Exhibiting at Booth 229 |
AI coordinator software that contacts and screens patients for clinical trial recruitment in many languages and supports treatment planning. | Booth Exhibiting at Booth 670 |
Clinical trial laboratory services company providing central lab testing and specialty assays for drug and vaccine trials. | Booth Exhibiting at Booth 356 |
Cores Deventer, Netherlands | |
Contract research organization for infectious disease and zoonoses research, offering bioanalytical services and preclinical studies; part of GD Group. | Booth Exhibiting at Booth 348 |
Instantly find 20 buyers in clinical & preclinical development
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress 2027 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction